This video explains the challenges of removing spike proteins and persistent viruses from the body, highlighting the importance of antiviral strategies in preventing reinfection. It also discusses the mechanisms of viral entry and the impact of lipid nanoparticles from vaccines on cellular health.
Navigating Spike Protein Detox and Viral Persistence Read More »
This video discusses how viral-infected, senescent cells resist autophagy and remain inflamed, contributing to long-term health issues. It explores the role of autophagy in addressing cellular dysfunction, with implications for metabolic disorders and cancer prevention.
Autophagy Blockade Viral Persistence and Cellular Dysfunction Read More »
This video explores the potential cancer-causing effects of the SARS-CoV-2 virus and its spike protein, particularly highlighting a case where a cancer patient experienced a rapid resurgence of tumors after receiving a vaccine booster. A study suggests that pseudouridine, found in certain mRNA vaccines, may contribute to this phenomenon, as animal models showed rapid cancer
Spike Protein and mRNA Vaccines: Uncovering Cancer Risks Read More »
Dr.Kevin Mccairn and Joachim Gerlach
Can Sars-CoV-2/Spike proteins cause Prion Disease? Read More »
“Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols” published in Inflammopharmacology is a comprehensive review exploring the complex nature of long COVID. https://link.springer.com/article/10.1007/s10787-024-01483-2
The evidence suggests a strong link between SARS-CoV-2 infection, long COVID, and the development or acceleration of neurodegenerative diseases. The mechanisms underlying this relationship appear to involve the prion-like properties of the SARS-CoV-2 spike protein, shared inflammatory pathways, and the widespread distribution of the ACE2 receptor in the brain. Further research is needed to fully
SARS-CoV-2, long COVID, prion disease and neurodegeneration Read More »
The document titled “Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?” authored by Alberto Rubio-Casillas and colleagues, provides a comprehensive review of the role of N1-methyl-pseudouridine (m1Ψ) in the context of cancer, particularly focusing on its implications when used in mRNA vaccines, such as those developed for COVID-19. The review highlights the rapid development and
Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer? Read More »
The article from Future Virology, authored by J Gerlach and AM Baig, discusses the effects of COVID-19 and vaccination on the human immune system, particularly focusing on cases of lymphopenia and autoimmunity. The study explores the possibility that some individuals may be more prone to developing an immune response to self-antigens after COVID-19 infection and
Based on the additional search results provided, the key information about the “spike532” sequence and its relation to prion protein biogenesis is: The spike532 sequence refers to a specific region within the SARS-CoV-2 spike protein that has been identified as having prion-like properties[2]. Specifically, the search results indicate that the spike532 sequence contains signal sequences
SARS-COV-2 Spike Protein causes prionlike diseases Read More »
We show that inoculation of recPrP fibrils does not cause TSE disease, but, instead, seeds the formation of PrP amyloid plaques in PrP-P101L knock-in transgenic mice (101LL). Importantly, both WT-recPrP fibrils and 101L-recPrP fibrils can seed plaque formation, indicating that the fibrillar conformation, and not the primary sequence of PrP in the inoculum, is important
© 2024 Healthcare Channel. All Rights Reserved.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.